Cargando…

Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment

Detalles Bibliográficos
Autores principales:	Zethoven, Magnus, Martelotto, Luciano, Pattison, Andrew, Bowen, Blake, Balachander, Shiva, Flynn, Aidan, Rossello, Fernando J., Hogg, Annette, Miller, Julie A., Frysak, Zdenek, Grimmond, Sean, Fishbein, Lauren, Tischler, Arthur S., Gill, Anthony J., Hicks, Rodney J., Dahia, Patricia L. M., Clifton-Bligh, Roderick, Pacak, Karel, Tothill, Richard W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829661/ https://www.ncbi.nlm.nih.gov/pubmed/36624099 http://dx.doi.org/10.1038/s41467-022-35751-y

Ejemplares similares

Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment
por: Zethoven, Magnus, et al.
Publicado: (2022)

The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
por: Clifton-Bligh, Roderick J.
Publicado: (2023)

Deep Membrane Proteome Profiling Reveals Overexpression of Prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity
por: Vit, Ondrej, et al.
Publicado: (2021)

(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
por: Chang, Chian A., et al.
Publicado: (2016)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma
por: Dwight, Trisha, et al.
Publicado: (2017)

New insights on the pathogenesis of paraganglioma and pheochromocytoma
por: Kantorovich, Vitaly, et al.
Publicado: (2018)

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
por: Ben Aim, Laurene, et al.
Publicado: (2022)

15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
por: Benn, Diana E, et al.
Publicado: (2015)

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma
por: Fuchs, Talia L., et al.
Publicado: (2023)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Novel Germline SUCLG2 Mutations in Patients With Pheochromocytoma and Paraganglioma
por: Vanova, Katerina Hadrava, et al.
Publicado: (2021)

The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study
por: Schovanek, Jan, et al.
Publicado: (2014)

Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
por: Ilanchezhian, Maran, et al.
Publicado: (2020)

Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
por: Hofman, MS, et al.
Publicado: (2015)

Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
por: Turin, Christie G, et al.
Publicado: (2022)

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
por: Mamilla, Divya, et al.
Publicado: (2019)

Pheochromocytoma and Paraganglioma: Current Functional and Future Molecular Imaging
por: Blanchet, Elise M., et al.
Publicado: (2012)

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
por: Pang, Ying, et al.
Publicado: (2019)

MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors
por: Ghayee, Hans Kumar, et al.
Publicado: (2020)

Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
por: Flores, Shahida K., et al.
Publicado: (2021)

THU612 SDHx Pheochromocytoma/Paraganglioma Has Elevation Of Arginine And Lysine Metabolites
por: Ghayee, Hans Kumar, et al.
Publicado: (2023)

Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches
por: Kuo, Mickey J. M., et al.
Publicado: (2022)

Metabolomics in paraganglioma: applications and perspectives from genetics to therapy
por: Richter, Susan, et al.
Publicado: (2023)

Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
por: Zhang, Liang, et al.
Publicado: (2023)

Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization
por: Vit, Ondrej, et al.
Publicado: (2023)

Cytocidal Activities of Topoisomerase 1 Inhibitors and 5-Azacytidine against Pheochromocytoma/Paraganglioma Cells in Primary Human Tumor Cultures and Mouse Cell Lines
por: Powers, James F., et al.
Publicado: (2014)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

Clinical Activity of Selpercatinib in RET Mutant Pheochromocytoma-Case Reports
por: Konda, Bhavana, et al.
Publicado: (2021)

New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications
por: Jhawar, Sakshi, et al.
Publicado: (2022)

External Beam Radiation Therapy in Treatment of Malignant Pheochromocytoma and Paraganglioma
por: Vogel, Jennifer, et al.
Publicado: (2014)

PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma
por: Hadrava Vanova, Katerina, et al.
Publicado: (2022)

OR34-6 A Novel Mechanism of SDH-Deficient Tumorigenesis and Implications for Genetic Testing in Patients with Pheochromocytoma-Paraganglioma
por: De Sousa, Sunita M.C., et al.
Publicado: (2019)

Reactive Oxygen Species: A Promising Therapeutic Target for SDHx-Mutated Pheochromocytoma and Paraganglioma
por: Hadrava Vanova, Katerina, et al.
Publicado: (2021)

Vascular Pattern Analysis for the Prediction of Clinical Behaviour in Pheochromocytomas and Paragangliomas
por: Oudijk, Lindsey, et al.
Publicado: (2015)

Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Molecular markers of paragangliomas/pheochromocytomas
por: Zhikrivetskaya, Svetlana O, et al.
Publicado: (2017)

Characteristics of Pediatric Pheochromocytoma/paraganglioma
por: Sarathi, Vijaya
Publicado: (2017)

Review of Pediatric Pheochromocytoma and Paraganglioma
por: Bholah, Reshma, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tpgommjn1p4dikj1oe29vgbb74